title: In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients.
authors.forename: C
authors.initials: C
authors.lastname: Grayson
authors.forename: J P
authors.initials: JP
authors.lastname: Chapple
authors.forename: K R
authors.initials: KR
authors.lastname: Willison
authors.forename: A R
authors.initials: AR
authors.lastname: Webster
authors.forename: A J
authors.initials: AJ
authors.lastname: Hardcastle
authors.forename: M E
authors.initials: ME
authors.lastname: Cheetham
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001120:Arginine / Q000235:genetics*; D016466:CHO Cells; D002460:Cell Line; D018389:Codon, Nonsense / Q000235:genetics*; D006224:Cricetinae; D005136:Eye Proteins; D019204:GTP-Binding Proteins; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008565:Membrane Proteins; D011506:Proteins / Q000235:genetics*; D012174:Retinitis Pigmentosa / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D018389:Codon, Nonsense; D005136:Eye Proteins; D005839:Gentamicins; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D011506:Proteins; C072178:RP2 protein, human; D001120:Arginine; D019204:GTP-Binding Proteins